Trastuzumab (Herceptin®) in patients with HER-2-overexpressing metastatic or locally advanced transitional cell carcinoma of the bladder: report on 7 patientsMarc Salzberg, Christoph Rochlitz, Markus Borner et al.|European Journal of Cancer|2006Cited by 22